SOTERA HEALTH COMPANY Gain (Loss) on Interest Rate Derivative Instruments Not Designated as Hedging Instruments
SOTERA HEALTH COMPANY (SHC) reported Gain (Loss) on Interest Rate Derivative Instruments Not Designated as Hedging Instruments of $6.30 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2023-05-03.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments · last filed 2023-05-03
- SOTERA HEALTH COMPANY gain (loss) on interest rate derivative instruments not designated as hedging instruments for the quarter ending 2022-03-31 was $6.30M.
| Period end | Gain (Loss) on Interest Rate Derivative Instruments Not Designated as Hedging Instruments 3 month |
|---|---|
| 2022-03-31 | $6.30M 10-Q · filed 2023-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |